Annual ROA
-408.56%
-121.29%-42.22%
December 31, 2023
Summary
- As of March 9, 2025, BCLI annual return on assets is -408.56%, with the most recent change of -121.29% (-42.22%) on December 31, 2023.
- During the last 3 years, BCLI annual ROA has fallen by -346.50% (-558.33%).
- BCLI annual ROA is now -916.57% below its all-time high of -40.19%, reached on March 31, 2002.
Performance
BCLI ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-372.85%
-103.39%-38.37%
September 30, 2024
Summary
- As of March 9, 2025, BCLI quarterly return on assets is -372.85%, with the most recent change of -103.39% (-38.37%) on September 30, 2024.
- Over the past year, BCLI quarterly ROA has dropped by -103.39% (-38.37%).
- BCLI quarterly ROA is now -3767.74% below its all-time high of -9.64%, reached on June 30, 2002.
Performance
BCLI Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
BCLI ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -42.2% | -38.4% |
| 3 y3 years | -558.3% | -38.4% |
| 5 y5 years | -228.9% | -38.4% |
BCLI ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -389.1% | at low | -489.3% | at low |
| 5 y | 5-year | -558.3% | at low | -489.3% | at low |
| alltime | all time | -916.6% | +80.9% | -3767.7% | +97.7% |
Brainstorm Cell Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -372.85%(+38.4%) |
| Jun 2024 | - | -269.46%(-17.7%) |
| Mar 2024 | - | -327.29%(+11.9%) |
| Dec 2023 | -408.56%(+42.2%) | -292.52%(+22.0%) |
| Sep 2023 | - | -239.72%(-4.9%) |
| Jun 2023 | - | -252.11%(+27.6%) |
| Mar 2023 | - | -197.59%(+35.2%) |
| Dec 2022 | -287.27%(+243.9%) | -146.12%(+25.3%) |
| Sep 2022 | - | -116.63%(+32.3%) |
| Jun 2022 | - | -88.16%(+25.5%) |
| Mar 2022 | - | -70.25%(+11.0%) |
| Dec 2021 | -83.54%(+34.6%) | -63.27%(-7.1%) |
| Sep 2021 | - | -68.13%(+1.8%) |
| Jun 2021 | - | -66.91%(-16.4%) |
| Mar 2021 | - | -80.03%(-23.7%) |
| Dec 2020 | -62.06%(-82.6%) | -104.95%(-27.5%) |
| Sep 2020 | - | -144.74%(-35.2%) |
| Jun 2020 | - | -223.36%(-12.5%) |
| Mar 2020 | - | -255.23%(-3.8%) |
| Dec 2019 | -355.88%(+186.5%) | -265.29%(+25.9%) |
| Sep 2019 | - | -210.74%(+30.3%) |
| Jun 2019 | - | -161.76%(+40.3%) |
| Mar 2019 | - | -115.28%(+14.5%) |
| Dec 2018 | -124.23%(+186.6%) | -100.65%(+68.8%) |
| Sep 2018 | - | -59.61%(+5.5%) |
| Jun 2018 | - | -56.52%(+3.9%) |
| Mar 2018 | - | -54.42%(+9.3%) |
| Dec 2017 | -43.35%(-6.3%) | -49.78%(-16.8%) |
| Sep 2017 | - | -59.81%(+16.9%) |
| Jun 2017 | - | -51.16%(+14.8%) |
| Mar 2017 | - | -44.56%(+10.6%) |
| Dec 2016 | -46.28%(-6.9%) | -40.29%(-2.2%) |
| Sep 2016 | - | -41.18%(-4.7%) |
| Jun 2016 | - | -43.19%(-6.5%) |
| Mar 2016 | - | -46.21%(+6.4%) |
| Dec 2015 | -49.70%(-46.7%) | -43.42%(-21.6%) |
| Sep 2015 | - | -55.39%(-8.1%) |
| Jun 2015 | - | -60.27%(-9.6%) |
| Mar 2015 | - | -66.67%(-31.4%) |
| Dec 2014 | -93.29%(-10.0%) | -97.25%(+3.3%) |
| Sep 2014 | - | -94.18%(+1.8%) |
| Jun 2014 | - | -92.48%(-26.2%) |
| Mar 2014 | - | -125.29%(+24.6%) |
| Dec 2013 | -103.66% | -100.57%(+17.4%) |
| Sep 2013 | - | -85.67%(-4.0%) |
| Jun 2013 | - | -89.23%(+7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | -83.41%(-9.1%) |
| Dec 2012 | -66.76%(-53.2%) | -91.75%(-32.6%) |
| Sep 2012 | - | -136.07%(-10.1%) |
| Jun 2012 | - | -151.39%(+9.8%) |
| Mar 2012 | - | -137.83%(+23.2%) |
| Dec 2011 | -142.78%(-35.7%) | -111.87%(+15.9%) |
| Sep 2011 | - | -96.55%(-15.4%) |
| Jun 2011 | - | -114.07%(-5.1%) |
| Mar 2011 | - | -120.19%(-26.2%) |
| Dec 2010 | -222.13%(-5.6%) | -162.92%(+12.2%) |
| Sep 2010 | - | -145.25%(-6.5%) |
| Jun 2010 | - | -155.34%(-9.6%) |
| Mar 2010 | - | -171.91%(-22.1%) |
| Dec 2009 | -235.27%(-40.7%) | -220.69%(-19.9%) |
| Sep 2009 | - | -275.43%(+2.6%) |
| Jun 2009 | - | -268.41%(-4.1%) |
| Mar 2009 | - | -280.03%(-16.6%) |
| Dec 2008 | -396.80%(-31.2%) | -335.95%(-23.3%) |
| Sep 2008 | - | -437.77%(-14.7%) |
| Jun 2008 | - | -513.19%(-15.0%) |
| Mar 2008 | - | -603.71%(-16.8%) |
| Dec 2007 | -576.55%(+6.2%) | -725.61%(+31.5%) |
| Sep 2007 | - | -551.65%(-1.7%) |
| Jun 2007 | - | -560.95%(+32.4%) |
| Mar 2007 | - | -423.55%(+4.3%) |
| Dec 2006 | -542.74%(+40.7%) | - |
| Sep 2006 | - | -406.20%(+3.6%) |
| Jun 2006 | - | -392.21%(-7.0%) |
| Mar 2006 | - | -421.54%(-0.6%) |
| Mar 2006 | -385.75%(-82.0%) | - |
| Dec 2005 | - | -424.29%(-83.9%) |
| Sep 2005 | - | -2639.00%(-28.8%) |
| Jun 2005 | - | -3706.74%(-35.6%) |
| Mar 2005 | -2142.35%(+373.5%) | -5757.68%(-64.7%) |
| Dec 2004 | - | -16.32 K%(+340.8%) |
| Sep 2004 | - | -3703.71%(+1739.4%) |
| Jun 2004 | - | -201.35%(-7.4%) |
| Mar 2004 | -452.47%(+427.5%) | -217.35%(+65.2%) |
| Dec 2003 | - | -131.55%(+13.4%) |
| Sep 2003 | - | -116.01%(+31.5%) |
| Jun 2003 | - | -88.20%(+30.5%) |
| Mar 2003 | -85.77%(+113.4%) | -67.58%(+72.1%) |
| Dec 2002 | - | -39.27%(+103.7%) |
| Sep 2002 | - | -19.28%(+100.0%) |
| Jun 2002 | - | -9.64% |
| Mar 2002 | -40.19% | - |
FAQ
- What is Brainstorm Cell Therapeutics annual return on assets?
- What is the all time high annual ROA for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics annual ROA year-on-year change?
- What is Brainstorm Cell Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics quarterly ROA year-on-year change?
What is Brainstorm Cell Therapeutics annual return on assets?
The current annual ROA of BCLI is -408.56%
What is the all time high annual ROA for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high annual return on assets is -40.19%
What is Brainstorm Cell Therapeutics annual ROA year-on-year change?
Over the past year, BCLI annual return on assets has changed by -121.29% (-42.22%)
What is Brainstorm Cell Therapeutics quarterly return on assets?
The current quarterly ROA of BCLI is -372.85%
What is the all time high quarterly ROA for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high quarterly return on assets is -9.64%
What is Brainstorm Cell Therapeutics quarterly ROA year-on-year change?
Over the past year, BCLI quarterly return on assets has changed by -103.39% (-38.37%)